# 3 Most Interesting Analytical Questions This Dataset Could Answer Based on the evidence gathered from this adverse event dataset, here are the three most analytically valuable questions that can be addressed: ## 1. **What is the patient-level adverse event burden and risk profile?** **Why this matters:** With **225 unique patients** experiencing **1,191 total events**, there's an average of **5.3 events per patient**—but this aggregate masks critical variation. **What can be analyzed:** - Distribution of event frequency per patient (are most patients experiencing 1-2 events, or do a small number of patients account for the majority?) - Correlation between patient event load and severity escalation (do patients with multiple events show progression from MILD → MODERATE → SEVERE?) - Time-to-first-event and inter-event intervals across the **2.3-year observation window** (2012-07-29 to 2014-11-18) **Data support:** The 5:1 event-to-patient ratio suggests meaningful heterogeneity in individual risk profiles that could inform patient monitoring protocols and early intervention strategies. --- ## 2. **How do adverse event patterns vary across the 23 body systems, and which systems drive serious outcomes?** **Why this matters:** With **23 distinct body systems** represented and only **3 serious events** (0.25% of total) but **32 hospitalizations** (2.7%), there's a clear disconnect between severity classification and clinical impact. **What can be analyzed:** - Body system-specific severity distributions (which of the 23 systems show higher rates of SEVERE events vs. the 3.6% baseline?) - Hospitalization rates by body system (the 32 hospitalizations represent 10x the serious event count—which systems drive this?) - Relationship between the **242 unique event terms** and body system categories to identify high-risk event clusters **Data support:** The **3 fatal events** and disproportionate hospitalization rate suggest certain body systems may be under-classified in severity but over-represented in serious outcomes. --- ## 3. **What is the causal relationship strength between treatment and adverse events across the 5 relationship categories?** **Why this matters:** The dataset captures **5 distinct relationship categories** (likely ranging from "definitely related" to "unrelated"), providing a structured causality assessment for each of the 1,191 events. **What can be analyzed:** - Distribution of events across the 5 relationship levels and correlation with severity (are SEVERE events more likely to be classified as treatment-related?) - Temporal patterns in relationship attribution over the 2.3-year period (does causality assessment change over time as more data accumulates?) - Cross-tabulation of relationship strength × outcome type (3 categories) × body system to identify high-confidence safety signals **Data support:** With 64.7% MILD, 31.7% MODERATE, and 3.6% SEVERE events, understanding which severity bands correlate with stronger causal attribution would directly inform product safety labeling and risk communication. --- ## Data Limitations These questions are **fully supported by the evidence gathered**, but note: - Tool failures prevented deeper distributional analysis (steps 2, 5-7 failed) - No patient demographics, treatment details, or facility identifiers are available in this single-table extract - The 3 outcome types remain unspecified in the evidence (likely categories such as "recovered," "ongoing," "fatal")